Shelli Meyer Email & Phone Number

Denver, Co, Us

• Launched Eliquis, the #1 OAC (oral anticoagulant) in sales territory; continuously resides above the nation YOY in market share.• Represented Plavix, a first & only FDA-approved agent in a new class of therapy; exceeded sales goals YOY until drug went generic in 2012.• Represents 183 doctors in the Denver Metro area including, cardiologists, oncologists, & high-volume primary care physicians.• Works cross-functionally with colleagues & executives (medical liaisons, key account managers, & regional account executives) to maximize coverage of top prescribers. • Developed a number of key partnerships in medical network with doctors & staff at top hospitals & clinics to get Eliquis and Tequin on their hospital formularies in 2 states; Colorado (SCL and Centura) and Portland (Providence, Legacy, and Oregon Health and Science University).• Develops professional relationships with key physicians and prior authorization staff in the cardiology clinical departments to assure Eliquis is covered for Medicaid & other non-formulary insurances.• Analyzes weekly data for low prescription numbers to retarget efforts to specific doctors.• Develops key speakers to assure they are up to date on data, information, contracts, news, etc. assuring that they meet their requirements & represent Eliquis accurately to KOL’s.• Annually hosts teleconferences, dinner programs, & live office speaking engagements over lunch; efforts increase doctor’s knowledge of drug utilization & ensures higher sales.• Specialty markets represented: Neurology, Oncology, Cardiology, Psychiatry, Pediatrics, Infectious Disease, Diabetes, Hospitalists, Nephrology, Primary Care, & Urology.• Sales arenas: Hospitals, Coumadin Clinics, Urgent Cares, Cardiology Cath Labs, Doctor’s Offices, & Emergency Rooms.• Represented drugs: Eliquis, Plavix, Tequin, Coumadin, Avapro/Avalide, Pravachol, Serzone, Buspar, Cefzil, Glucophage/Glucophage XR, & Onglyza.• Recipient of the Pinnacle Sales Award 2001, 2007, & 2010.